Axonics Modulation Technologies Inc. (NASDAQ: AXNX) stock closed at 50.85 per share at the end of the most recent trading day (a 3.42% change compared to the prior day closing price) with a volume of 628.71K shares and market capitalization of 2.58B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 302 people. Axonics Modulation Technologies Inc. CEO is Raymond Wayne Cohen.

The one-year performance of Axonics Modulation Technologies Inc. stock is -12.27%, while year-to-date (YTD) performance is -18.68%. AXNX stock has a five-year performance of %. Its 52-week range is between 46.57 and 79.915, which gives AXNX stock a 52-week price range ratio of 13.87%

Axonics Modulation Technologies Inc. currently has a PE ratio of -36.40, a price-to-book (PB) ratio of 5.38, a price-to-sale (PS) ratio of 14.51, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -13.64%, a ROC of -14.09% and a ROE of -15.66%. The company’s profit margin is -32.14%, its EBITDA margin is -27.30%, and its revenue ttm is $187.78 Million , which makes it $3.79 revenue per share.

Of the last four earnings reports from Axonics Modulation Technologies Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.34 for the next earnings report. Axonics Modulation Technologies Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Axonics Modulation Technologies Inc. is Moderate Buy (1.55), with a target price of $82.67, which is +61.99% compared to the current price. The earnings rating for Axonics Modulation Technologies Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axonics Modulation Technologies Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axonics Modulation Technologies Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.41, ATR14 : 1.98, CCI20 : -29.58, Chaikin Money Flow : -0.16, MACD : -1.61, Money Flow Index : 25.96, ROC : 1.03, RSI : 47.23, STOCH (14,3) : 51.58, STOCH RSI : 1.00, UO : 52.49, Williams %R : -48.42), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axonics Modulation Technologies Inc. in the last 12-months were: Alfred J. Ford (Option Excercise at a value of $486 817), Alfred J. Ford (Sold 36 015 shares of value $2 391 415 ), Cohen Raymond (Sold 44 000 shares of value $3 099 351 ), Danny L. Dearen (Option Excercise at a value of $1 810 769), Danny L. Dearen (Sold 225 314 shares of value $15 039 386 ), Esteban Lopez (Sold 2 000 shares of value $134 840 ), Jane E. Kiernan (Sold 5 250 shares of value $315 000 ), John Woock (Option Excercise at a value of $550 904), John Woock (Sold 45 215 shares of value $3 159 579 ), Karen Noblett (Option Excercise at a value of $623 335), Karen Noblett (Sold 32 483 shares of value $2 538 799 ), Kiernan Jane (Sold 5 250 shares of value $315 000 ), Raymond Wayne Cohen (Sold 84 736 shares of value $5 785 326 ), Rinda Sama (Sold 36 415 shares of value $2 241 166 ), Sama Rinda (Sold 0 shares of value $-576 872 ), Sama Rinda (Sold 70 265 shares of value $4 596 018 ), Woock John (Sold 0 shares of value $-12 225 ), Woock John (Sold 22 500 shares of value $1 592 771 )